Multiple Myeloma Clinical Trials in Chicago

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +3 more
2021-10-14
Oct 14, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2021-10-14
Oct 14, 2021
C
Recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
2021-10-07
Oct 7, 2021
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2021-10-06
Oct 6, 2021
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2021-09-30
Sep 30, 2021
N
Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +13 more
2021-09-30
Sep 30, 2021
U
Recruiting
  • Myeloma
  • Multiple Myeloma
  • Chicago, Illinois
    The University of Chicago
2021-09-15
Sep 15, 2021
C
Recruiting
  • Multiple Myeloma
  • BB2121
  • +5 more
  • Birmingham, Alabama
  • +23 more
2021-09-14
Sep 14, 2021
P
Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
2021-09-10
Sep 10, 2021
O
Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +19 more
2021-08-27
Aug 27, 2021
C
Available
  • Multiple Myeloma
  • Nonconforming idecabtagene vicleucel
  • Birmingham, Alabama
  • +77 more
2021-08-18
Aug 18, 2021
A
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
2021-08-16
Aug 16, 2021